Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis Guldsten HActa Ophthalmol (Copenh) 1983[Feb]; 61 (1): 51-7Eight patients with active toxoplasmic retinochoroiditis were treated with clindamycin and a triple sulphonamide combination for a period of up to 6 weeks. In addition systemic prednisone was administered when the optic nerve or the macula was involved (6 of the 8 cases). In all cases we observed clinical improvement within 2 weeks. Visual acuity improved in all cases. Side effects of the treatment were observed in 2 cases. The follow-up period ranged from 8 to 22 months.|Adolescent[MESH]|Adult[MESH]|Child[MESH]|Clindamycin/*therapeutic use[MESH]|Drug Combinations[MESH]|Drug Therapy, Combination[MESH]|Female[MESH]|Fluorescein Angiography[MESH]|Follow-Up Studies[MESH]|Humans[MESH]|Male[MESH]|Prednisone/*therapeutic use[MESH]|Recurrence[MESH]|Sulfadiazine/therapeutic use[MESH]|Sulfamethazine/therapeutic use[MESH]|Sulfanilamides/therapeutic use[MESH]|Sulfonamides/*therapeutic use[MESH]|Toxoplasmosis, Ocular/*drug therapy[MESH]|Visual Acuity[MESH] |